. Determination of the recognition sequence of the monoclonal antibodies. Figure S2 . Swi5-Sfr1 and Fab fragments of Sfr1-specific monoclonal antibodies form stable complexes. Figure S3 . Disorder probability of Sfr1.
Upper. Schematic of the series of the Sfr1 N-terminal truncation constructs. Every five amino acid residues were truncated from the N-terminus (F1 to F40) and the truncated Sfr1 peptides were expressed in a T7 expression system. Only the truncated constructs important for the determination of the recognition sequence are presented in the panel. Lower. A pair of the important crude extracts of E. coli cells expressing the Sfr1 peptides was separated by SDS-PAGE, followed by visualization with Coomassie brilliant blue (CBB) or immunoblotting with four specific antibodies (#7, #19, #49 and #63) Black arrow-heads in the CBB-stained gels correspond to the Sfr1 protein. Figure S3. Disorder probability of Sfr1. Disorder probability of Sfr1 was calculated from the primary sequence by using DISOPRED. The N-terminal half of Sfr1 has high IDP propensity.
